Absorbing the Cost of Personalized Medicine

Is Immunotherapy Appropriate Here?

Dr Morganna Freeman on the challenge of deciding when to treat a patient with immunotherapy.

Exploring the Uses of Fulvestrant

Dr Sibylle Loibl explains how fulvestrant (with or without palbociclib) fits in the treatment paradigm for patients with HR+/ HER2-negative metastatic breast cancer.